This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire sorbitol industry chain, from market dynamics to price update.
Welcome to the June issue of Sorbitol China News
- In terms of company performance, Huakang Pharma held a performance briefing to give an update on its business conditions and its project.
- As for company dynamics, Perfect's subsidiary successfully bid for a 1.59% stake in Weimeizi; Northeast Pharm received the CEP certificate for its vitamin C API.
- Regarding downstream sectors, Luwei Pharmaceutical plans to shut down the vitamin C production line for the 4-month maintenance starting on 15 June.
- In the export market, China exported 19,633.33 tonnes of sorbitol (down 3.30% MoM) valued at USD14,053,778 (down 6.46% MoM) to 65 countries and regions in May.
- In this monthly report, the USD/CNY exchange rate is USD1.00=CNY7.1086 (Source:The People's Bank of China, 3 June, 2024). Unless otherwise stated, all prices involved in this report include VAT.
Table of Contents
- Headline
- Editor's Note
- Market Dynamics
- Huakang Pharma performance briefing
- Oral care products manufacturer Perfect increases stake in Weimeizi
- Luwei Pharmaceutical planning vitamin C line maintenance
- Northeast Pharm's vitamin C API receives CEP certificate
- Analysis on China sorbitol exports in May 2024
- Price Update
- China's ex-works prices of sorbitol, June 2024
Companies Mentioned
- Zhejiang Huakang Pharmaceutical Co., Ltd.
- Perfect Group Corp., Ltd.
- Luwei Pharmaceutical Group Co., Ltd.
- Northeast Pharmaceutical Group Co., Ltd.
